Total Value
$346.17B
Holdings Count
15
Period of Report
Jun 30, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| MERUS N V | N5749R100 | $82.52B | 1,568,841 |
| GH RESEARCH PLC | G3855L106 | $82.25B | 6,746,951 |
| STOKE THERAPEUTICS INC | 86150R107 | $61.34B | 5,404,674 |
| PROTAGONIST THERAPEUTICS INC | 74366E102 | $40.51B | 733,014 |
| CULLINAN THERAPEUTICS INC | 230031106 | $33.14B | 4,400,842 |
| ALLOGENE THERAPEUTICS INC | 019770106 | $12.49B | 11,057,009 |
| TSCAN THERAPEUTICS INC | 89854M101 | $11.39B | 7,857,347 |
| C4 THERAPEUTICS INC | 12529R107 | $10.15B | 7,098,133 |
| PRECISION BIOSCIENCES INC | 74019P207 | $4.35B | 1,036,051 |
| PASSAGE BIO INC | 702712100 | $3.71B | 9,256,953 |
| UPSTREAM BIO INC | 91678A107 | $2.41B | 219,247 |
| IBIO INC | 451033708 | $1.17B | 1,538,573 |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | $325.2M | 45,806 |
| DESIGN THERAPEUTICS INC | 25056L103 | $222.3M | 65,954 |
| ASSEMBLY BIOSCIENCES INC | 045396207 | $187.8M | 10,366 |